Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 706 of 1,261
  1. US 9272137

    Transdermal methods and systems for the delivery of anti-migraine compounds

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  2. US 9272028

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  3. US 9271960

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    PTC THERAPEUTICS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  4. US 9271962

    Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors

    Northwestern University · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  5. US 9271985

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  6. US 9271965

    Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  7. US 9273284

    Method for generating potent dendritic cells

    The Regents of the University of California · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  8. US 9273315

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  9. US 9273191

    Medical devices with an activated coating

    Covidien LP · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  10. US 9271937

    Oxidized cellulose microspheres

    Covidien LP · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  11. US 9271901

    One-part dental adhesive composition

    KURARAY NORITAKE DENTAL INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  12. US 9273288

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  13. US 9273136

    Fully human anti-human NKG2D monoclonal antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  14. US 9273124

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  15. US 9273093

    α4β7 peptide dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  16. US 9273121

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  17. US 9273076

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  18. US 9272009

    Method for increasing performance of offspring

    JBS UNITED, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  19. US 9272991

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  20. US 9272978

    Hydroxy acid ester compound of substituted phenol, preparation method and medical use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  21. US 9272055

    Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles

    The Regents of the University of California · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  22. US 9272051

    Methods and systems for modulating hormones and related methods, agents and compositions

    The United States Government represented by the Department of Veterans Affairs · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  23. US 9272044

    Injectable flowable composition buprenorphine

    Indivior UK Limited · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  24. US 9271950

    Compositions for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.